Acrivon Therapeutics
Clinical trials sponsored by Acrivon Therapeutics, explained in plain language.
-
Personalized cancer treatment trial seeks to shrink tumors
Disease control Recruiting nowThis study is testing whether a new drug called ACR-368 can shrink tumors in people with advanced endometrial cancer that has spread or returned after previous treatments. About 353 participants will receive either ACR-368 alone or combined with a low-dose sensitizing drug, depen…
Phase: PHASE2 • Sponsor: Acrivon Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New cancer drug begins first human testing
Disease control Recruiting nowThis is the first human study of an experimental drug called ACR-2316 for people with advanced solid tumors that have spread or returned. The main goal is to find a safe dose and check how the body processes the drug. Researchers will also look for early signs that the drug might…
Phase: PHASE1 • Sponsor: Acrivon Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC